Pregnancy history and immunotherapy for gynecologic cancers
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at how previous pregnancies affect the response to immunotherapy in women with endometrial or cervical cancer. It aims to see if pregnancy history influences treatment outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are female
- You have been diagnosed with endometrial or cervical cancer
- You are being treated with immunotherapy (alone or combined with chemotherapy)
- You can provide written consent to participate
- If you have been pregnant before, your obstetric history must be available
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how immune checkpoint inhibitor (ICI) therapy—a type of cancer treatment that boosts your immune system—affects ovarian function and fertility in female cancer patients. It also explores the role of gut bacteria in these effects. The study aims to understand changes that may help guide fertility preservation decisions.
This trial looks at how a blood inflammation marker (CRP) changes when people with metastatic gynecologic cancers receive immunotherapy, sometimes together with palliative chemotherapy. The goal is to see patterns that may help doctors better understand and manage treatment responses to immunotherapy.
This study looks at how well immunotherapy works for advanced or recurrent endometrial and cervical cancer by checking certain markers in your blood and tissue. It aims to find out which patients might benefit most from this treatment.
This trial tests whether combining two immunotherapy drugs (iparomlimab and tuvonralimab) with standard chemotherapy (paclitaxel and cisplatin) before surgery can help shrink cervical cancer. It is for people with certain stages of cervical cancer who are candidates for surgery, including those who want to preserve their fertility.
This study looks at why some people with endometrial cancer respond well to immunotherapy. It uses samples of your tumor to help doctors better understand how to choose the right treatment for each person.
This study looks at how well immunotherapy (a type of cancer treatment that helps your immune system attack cancer cells) works for people with various types of cancer. You may join if you are already planning to receive this treatment, and the study will track your outcomes to help improve future care.
Hear when a new Gynecologic Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.